MSH|^~\&||COCDL|||201609261021||MDM^T04|MT_COCDL_MDM_DLDPTO.1.5300690|P|2.1|||||
PID|1||H001568942|H1223688|BRADSHAW^BABY^GIRL||20160919|F|^^^^^^M|W|205 TRAIL VIEW LN^^GARLAND^TX^75043|DAL|469-994-7311|.||S|NPR|H00732730634|000-00-0000
PV1|1|I|H.NICU^H.470N^2|UR|||KIMLI^Knox^Linda^Jane^^^MD^^^^^^XX|NYSGE^Nystrom^Gerald^A^^^MD^^^^^^XX|NYSGE^Nystrom^Gerald^A^^^MD^^^^^^XX|NIC||||TFR|||KIMLI^Knox^Linda^Jane^^^MD^^^^^^XX|IN||99|||||||||||||||||||COCDL||ADM|||201609190454||||||||EHRST^Ehrett^Stuart^W^^^MD^^^^^^XX
TXA||PDPNCUSCN^Clinical Note|201609261021|201609260607||201609260607|201609260607||GARCA03^Garcia^Carla^G^^^MD||H.PHY.CG^Garcia^Carla^^^^MD|BA.PDOC20160926-0043|||BA.PDOC|PDPNCUSCN|Draft|||||GARCA03^Garcia^Carla^G^^^MD^^^^^^^^201609260607
OBX|1|TX||| 
OBX|2|TX|||MEDICAL CITY DALLAS HOSPITAL(COCDL)             MEDICAL CITY CHILDRENS HOSPITAL
OBX|3|TX|||Clinical Note
OBX|4|TX|||REPORT#:0926-0043   REPORT STATUS:Draft
OBX|5|TX|||DATE:09/26/16  TIME:0607
OBX|6|TX|||  
OBX|7|TX|||PATIENT: BRADSHAW,BABY GIRL             UNIT #: H001568942
OBX|8|TX|||ACCOUNT#: H00732730634                  ROOM/BED: H.470N-2
OBX|9|TX|||DOB: 09/19/16  AGE: 00M 07D SEX: F      ATTEND: Knox,Linda Jane  MD
OBX|10|TX|||ADM DT: 09/19/16                        AUTHOR: Garcia,Carla G  MD
OBX|11|TX|||REP SRV DT: 09/26/16                    REP SRV TM: 0607
OBX|12|TX|||* ALL edits or amendments must be made on the electronic/computer document *
OBX|13|TX||| 
OBX|14|TX||| 
OBX|15|TX|||Clinical Note
OBX|16|TX|||Note:
OBX|17|TX|||Pediatric Infectious Diseases Critical Care Services (seen @ 0810)  
OBX|18|TX|||Chart/notes, clinical lab tests,   imaging tests reviewed comprehensively. 
OBX|19|TX|||Clinical summary flowchart prepared and analyzed. Pertinent findings recorded.
OBX|20|TX|||Discussed with: ICN-team Dr Schwendeman
OBX|21|TX|||Antibiotics: cefotaxime (s/p ampicillin/gentamicin)
OBX|22|TX||| 
OBX|23|TX|||Subjective:
OBX|24|TX||| 
OBX|25|TX|||CC: Sepsis
OBX|26|TX|||Interval HPI: no significant change from visit on 9/25 except as noted: NSC
OBX|27|TX||| 
OBX|28|TX|||Interval ROS: no significant change from visit on 9/25 except as noted: NSC
OBX|29|TX||| 
OBX|30|TX|||Objective:
OBX|31|TX||| 
OBX|32|TX|||PE: Insofar as exam feasible, no signif. change from visit on 9/25 except as 
OBX|33|TX|||noted: NSC
OBX|34|TX|||(complete exam components on file @ PID Assoc, PA)
OBX|35|TX||| 
OBX|36|TX|||VS:  See flowsheet: CPAP
OBX|37|TX|||Constitutional:General:                  
OBX|38|TX|||Eyes: (incl conj; lids; pupil; iris)         
OBX|39|TX|||ENT: (incl ext ears; nose; OP; mouth)      
OBX|40|TX|||Neck: (incl neck; thyroid)             
OBX|41|TX|||Resp: (incl effort; perc; palp; ausc)         
OBX|42|TX|||CV: (incl palp; ausc)               
OBX|43|TX|||Abd: (incl mass; pain; L/S; hernia) soft         
OBX|44|TX|||GU: (incl ext genitalia; bladder)            
OBX|45|TX|||Lymphatic: (incl neck; axillae; groin)         
OBX|46|TX|||Musculoskeletal: (inspect; palp; ROM)      
OBX|47|TX|||Skin: (incl inspect; palp)             
OBX|48|TX|||Neuro: (incl DTR; mental status; tone; motor)   
OBX|49|TX|||   
OBX|50|TX|||Pertinent lab, culture, imaging and other results:   
OBX|51|TX||| 
OBX|52|TX|||9/26: WBC 40,800 (P67 B3); Plt 347K; Cr 0.32
OBX|53|TX|||9/25: WBC 50,900 (P82 B5); Plt 322K; Cr 0.5; KUB: no pneumatosis
OBX|54|TX|||9/24: WBC 51,600 (P69 B7); Plt 307K; Cr 0.7
OBX|55|TX|||9/23: WBC 47,900 (P56 B10 immature 4); Plt 304K; Cr 0.7; CRP <0.29
OBX|56|TX|||9/22: WBC 39,100 (P61); Plt 259K; gent P 13.9; 
OBX|57|TX|||9/21: WBC 37,200 (P54 B12 immature 6); Plt 206K; 
OBX|58|TX|||9/20: WBC 30,200 (P63 B10 immature 3); Plt 167K; CSF TNC 6 prot 165 gluc 69; 
OBX|59|TX|||gram stain: no org, CSF cx-NGSF; BC-NGSF
OBX|60|TX|||9/19: WBC 21,700 (P74 B1); Plt 146K; RPR NR; UDS: opiates/amphetamines
OBX|61|TX||| 
OBX|62|TX|||OSH BC 9/19: Haemophilus influenzae (betalactamase negative)/Bacillus sp (later 
OBX|63|TX|||likely a contaminant) 
OBX|64|TX||| 
OBX|65|TX|||Assessment:
OBX|66|TX||| 
OBX|67|TX|||1. Neonatal sepsis/bacteremia: H influenzae
OBX|68|TX|||2. Leukocytosis-possibly reactive/bandemia/left shift
OBX|69|TX|||3. Maternal drug use
OBX|70|TX|||4. Prematurity
OBX|71|TX||| 
OBX|72|TX|||Plan/Recommendations:
OBX|73|TX||| 
OBX|74|TX|||Specific:
OBX|75|TX|||1. Continue cefotaxime (would treat for 10 days depending on clinical course).
OBX|76|TX|||2. Monitor clinically, CBC/CRP
OBX|77|TX||| 
OBX|78|TX|||General:
OBX|79|TX|||1. If the patient s condition deteriorates, please call to discuss management.
OBX|80|TX|||2. Observe carefully for new or evolving findings.
OBX|81|TX|||3. Follow pending micro studies.
OBX|82|TX|||4. If renal function changes, may need to adjust antimicrobial doses.
OBX|83|TX|||5. Infection control management, including isolation procedures, per hospital
OBX|84|TX|||    infection control department.
OBX|85|TX||| 
OBX|86|TX|||Treatment provided for "vital organ failure" and/or "prevention of further life-
OBX|87|TX|||threatening deterioration of the patient s condition". Treatment required highly
OBX|88|TX|||complex level of decision-making. Patient is at high risk of significant 
OBX|89|TX|||complications  /or morbidity/mortality. Total critical care time spent: 30 min. 
OBX|90|TX|||No other physician nor NPP provided concurrent critical care services during 
OBX|91|TX|||this time.
OBX|92|TX||| 
OBX|93|TX|||  
OBX|94|TX|||RPT #: 0926-0043
OBX|95|TX|||***END OF REPORT***
OBX|96|TX|||  
OBX|97|TX|||  